Sodium-glucose cotransporter inhibition prevents oxidative stress in the kidney of diabetic rats

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Osorio, Horacio ^a   Coronel, Israel ^b   Arellano, Abraham ^a   Pacheco, Ursino ^a   Bautista, Rocío ^a   Franco, Martha ^a   Escalante, Bruno ^c  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD ANÁHUAC   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

3-NITROTYROSINE; DIABETIC NEPHROPATHY; DIABETIC RATS; GLUTATHIONE PEROXIDASE; IMMUNOHISTOCHEMICAL ANALYSIS; INTRAPERITONEAL INJECTIONS; LOWER BODY; STREPTOZOTOCIN; SUPEROXIDE DISMUTASE ACTIVITIES;

GLUCOSE; OXIDATIVE STRESS; OXYGEN; SODIUM;

RATS;

3 NITROTYROSINE; CATALASE; GLUTATHIONE PEROXIDASE; INSULIN; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER; STREPTOZOCIN; SUPEROXIDE DISMUTASE; 3-NITROTYROSINE; DRUG DERIVATIVE; SGLT2 PROTEIN, RAT; SODIUM GLUCOSE COTRANSPORTER 2; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CONTROLLED STUDY; DIURESIS; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSURIA; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MEDULLA OBLONGATA; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; URINALYSIS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE PEROXIDASE; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; OXIDATIVE STRESS; PHLORHIZIN; RATS; RATS, WISTAR; SODIUM-GLUCOSE TRANSPORTER 2; SUPEROXIDE DISMUTASE; TYROSINE;

EID: 84871369220     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/542042     Document Type: Article

References (32)

1. Shamoon H., Duffy H., Fleischer N., Engel S., Saenger P., Strelzyn M., Litwak M., Wylie-Rosett J., Farkash A., Geiger D., Engel H., Fleischman J., Pompi D., Ginsberg N., Glover M., Brisman M., Walker E., Thomashunis A., Gonzalez J., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 14 977 986 2-s2.0-0027370108 10.1056/NEJM199309303291401 (Pubitemid 23307905)
2. Bagby S. P., Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity. Kidney International 2007 71 12 1199 1202 2-s2.0-34250026180 10.1038/sj.ki.5002286 (Pubitemid 46884264)
3. Vallon V., The proximal tubule in the pathophysiology of the diabetic kidney. The American Journal of Physiology 2011 300 5 R1009 R1022 2-s2.0-79955771730 10.1152/ajpregu.00809.2010
4. Garg M. C., Ojha S., Bansal D. D., Antioxidant status of streptozotocin diabetic rats. Indian Journal of Experimental Biology 1996 34 3 264 266 2-s2.0-0029934761 (Pubitemid 26247847)
5. Ha H., Lee H. B., Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology 2005 10 supplement 2 S7 S10 2-s2.0-28544448737 10.1111/j.1440-1797.2005.00448.x (Pubitemid 41743468)
6. Osorio H., Bautista R., Rios A., Franco M., Santamaría J., Escalante B., Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats. Diabetes Research and Clinical Practice 2009 86 3 e46 e49 2-s2.0-70350618767 10.1016/j.diabres.2009.09.006
7. Osorio H., Bautista R., Rios A., Franco M., Arellano A., Vargas-Robles H., Romo E., Escalante B., Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats. Journal of Nephrology 2010 23 5 541 546 2-s2.0-78049422043
8. Osorio H., Coronel I., Arellano A., Franco M., Escalante B., Bautista R., Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats. Diabetes Research and Clinical Practice 2012 97 2 276 282
9. Asano T., Anai M., Sakoda H., Fujishiro M., Ono H., Kurihara H., Uchijima Y., SGLT as a therapeutic target. Drugs of the Future 2004 29 5 461 466 2-s2.0-3242890250 10.1358/dof.2004.029.05.850959 (Pubitemid 38997624)
10. Handlon A. L., Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents. Expert Opinion on Therapeutic Patents 2005 15 11 1531 1540 2-s2.0-27944488002 10.1517/13543776.15.11.1531 (Pubitemid 41671615)
11. Janssen S. W., Martens G. J., Sweep C. G., Span P. N., Verhofstad A. A. J., Hermus A. R. M. M., Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats. Journal of Endocrinological Investigation 2003 26 6 508 515 2-s2.0-0041524014 (Pubitemid 36998698)
12. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
13. Aebi H., Catalase in vitro. Methods in Enzymology 1984 105 121 126 2-s2.0-0021318441 10.1016/S0076-6879(84)05016-3
14. Lawrence R. A., Burk R. F., Glutathione peroxidase activity in selenium deficient rat liver. Biochemical and Biophysical Research Communications 1976 71 4 952 958 2-s2.0-0017067418
15. Sun Y., Oberley L. W., Li Y., A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 1988 34 3 497 500 2-s2.0-0023952554
16. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
17. Ha H., Kim K. H., Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Research and Clinical Practice 1999 45 2-3 147 151 2-s2.0-0344548772 10.1016/S0168-8227(99)00044-3 (Pubitemid 29457762)
18. Gilbert R. E., Cooper M. E., The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney International 1999 56 5 1627 1637 2-s2.0-0032731318 10.1046/j.1523-1755.1999. 00721.x (Pubitemid 29518163)
19. Bank N., Aynedjian H. S., Progressive increases in luminal glucose stimulate proximal sodium absorption in normal and diabetic rats. Journal of Clinical Investigation 1990 86 1 309 316 2-s2.0-0025351228 (Pubitemid 20227006)
20. Noonan W. T., Shapiro V. M., Banks R. O., Renal glucose reabsorption during hypertonic glucose infusion in female streptozotocin-induced diabetic rats. Life Sciences 2001 68 26 2967 2977 2-s2.0-0035906916 10.1016/S0024- 3205(01)01090-6 (Pubitemid 32453264)
21. Sechi L. A., Ceriello A., Griffin C. A., Catena C., Amstad P., Schambelan M., Bartoli E., Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 1997 40 1 23 29 2-s2.0-0031013176 10.1007/s001250050638 (Pubitemid 27035706)
22. Horie K., Miyata T., Maeda K., Miyata S., Sugiyama S., Sakai H., van Ypersele de Strihou C., Monnier V. M., Witztum J. L., Kurokawa K., Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. Journal of Clinical Investigation 1997 100 12 2995 3004 2-s2.0-0031453830 (Pubitemid 28022836)
23. Ha H., Kim C., Son Y., Chung M. H., Kim K. H., DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radical Biology and Medicine 1994 16 2 271 274 2-s2.0-0028348166 10.1016/0891-5849(94)90152-X (Pubitemid 24117509)
24. Halliwell B., What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo. FEBS Letters 1997 411 2-3 157 160 2-s2.0-0031567576 10.1016/S0014-5793(97)00469-9 (Pubitemid 27301445)
25. Pacher P., Obrosova I., Mabley J., Szabó C., Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications: emerging new therapeutical strategies. Current Medicinal Chemistry 2005 12 3 267 275 2-s2.0-14544297961 (Pubitemid 40305619)
26. Ishii N., Patel K. P., Lane P. H., Taylor T., Bian K., Murad F., Pollock J. S., Carmines P. K., Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. Journal of the American Society of Nephrology 2001 12 8 1630 1639 2-s2.0-0034920828 (Pubitemid 32674425)
27. Onozato M. L., Tojo A., Goto A., Fujita T., Wilcox C. S., Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney International 2002 61 1 186 194 2-s2.0-0036145348 10.1046/j.1523-1755.2002.00123.x (Pubitemid 34075146)
28. Thuraisingham R. C., Nott C. A., Dodd S. M., Yaqoob M. M., Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney International 2000 57 5 1968 1972 2-s2.0-0034078563 10.1046/j.1523-1755. 2000.00046.x (Pubitemid 30252288)
29. Malatiali S., Francis I., Barac N. M., Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats. Experimental Diabetes Research 2008 2008 7 2-s2.0-56149087069 10.1155/2008/305403 305403
30. +-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism 2000 49 8 990 995 2-s2.0-0033870323 10.1053/meta.2000.7729 (Pubitemid 30641434)
31. +-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes 1999 48 9 1794 1800 2-s2.0-0032850016 10.2337/diabetes.48.9.1794 (Pubitemid 29415199)
32. +-glucose cotransporter inhibitor T-1095. British Journal of Pharmacology 2001 132 2 578 586 2-s2.0-0035122471 (Pubitemid 32142370)